Sudarshan Pharma Set for NSE Main Board Listing Following BSE SME Platform Migration
Sudarshan Pharma Industries migrates from BSE SME to NSE Main Board on October 27, 2026. Company reports 35.5% YoY profit growth and ₹752.06 Cr market cap.
Friday, 23 October 2026
NSE & BSE filings, as they land
ALFA News
Straight from the exchange filing